DC-SIGN/CD209 antibody (N-Term)
Quick Overview for DC-SIGN/CD209 antibody (N-Term) (ABIN927998)
Target
See all DC-SIGN/CD209 (CD209) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- Purified
-
Immunogen
- CD209 antibody was raised in rabbit using the N terminal of CD209 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
CD209 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CD209 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- DC-SIGN/CD209 (CD209) (CD209)
-
Alternative Name
- CD209
-
Background
- This gene encodes a transmembrane receptor and is often referred to as DC-SIGN because of its expression on the surface of dendritic cells and macrophages. The encoded protein is involved in the innate immune system and recognizes numerous evolutionarily divergent pathogens ranging from parasites to viruses with a large impact on public health. Synonyms: Polyclonal CD209 antibody, Anti-CD209 antibody, CD209 molecule antibody, CDSIGN antibody, CLEC4L antibody, DC-SIGN antibody, DC-SIGN1 antibody, MGC129965 antibody.
Target
-